US74834L1008 - Common Stock
QUEST DIAGNOSTICS INC
NYSE:DGX (4/26/2024, 7:04:00 PM)
After market: 134.26 0 (0%)134.26
-1.16 (-0.86%)
Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information and services. The company is headquartered in Secaucus, New Jersey and currently employs 40,000 full-time employees. The firm operates through the DIS segment, which provides diagnostic information services to a range of customers, including patients, clinicians, hospitals, independent delivery networks (IDNs), health plans, employers, consumers, and accountable care organizations (ACOs). The company is also engaged in two business operations, Diagnostic Information Services, which develops and delivers diagnostic information services that provide insights to a range of customers, and the Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers, and its healthcare information technology business, which offers solutions for healthcare providers. The Company’s brands include the Quest Diagnostics brand, AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum. The firm also offers full-service laboratory services, which serves patients and physicians in Pennsylvania and Ohio.
QUEST DIAGNOSTICS INC
500 Plaza Drive
Secaucus NEW JERSEY 07094
P: 19735202700
CEO: Stephen H. Rusckowski
Employees: 40000
Website: https://www.questdiagnostics.com/
Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session.
DGX stock results show that Quest Diagnostics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
The US market session of Tuesday has yet to be opened, let's have a look at the top S&P500 gainers and losers in the pre-market session today.
/PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of diagnostic information services, today announced financial results for the...
/PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced the launch of a new blood biomarker test for...
Here you can normally see the latest stock twits on DGX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: